-
Mashup Score: 1A rapid facility-level assessment of oxygen systems in 39 low-income and middle-income countries: a cross-sectional study - 6 day(s) ago
Reliable oxygen availability was low across facility levels and subregions. There were significant disparities in the functional availability of oxygen system components across subregions, with important implications for global health equity and financing.
Source: www.thelancet.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 15Health Care Is About to Get Even More Litigious - 8 month(s) ago
Thanks to the Supreme Court’s decision to do away with Chevron deference, scientists and doctors can be second-guessed by lawyers and judges.
Source: www.bloomberg.comCategories: General Medicine News, PayerTweet-
The Supreme Court just made sweeping changes to regulators' power and that won't be good for the agencies protecting our health, including FDA and CMS https://t.co/ON3TkQL4Fe via @lisamjarvis @opinion
-
-
Mashup Score: 1Biomedical paper retractions have quadrupled in 20 years — why? - 9 month(s) ago
Nature – Unreliable data, falsification and other issues related to misconduct are driving a growing proportion of retractions.
Source: www.nature.comCategories: General Medicine News, PayerTweet-
RT @albertoruano8: Biomedical paper retractions have quadrupled in 20 years — why? https://t.co/Je3o3CXOzn @jsross119 @ivanoransky @Micro…
-
-
Mashup Score: 11Opinion | Is Industry Influence Driving LVAD Use by Cardiologists? - 11 month(s) ago
Clinical treatment decisions should be based on the best available evidence
Source: www.medpagetoday.comCategories: General Medicine News, PayerTweet-
Opinion | Industry influence seems to be driving LVAD use by cardiologists. How can we be sure clinical decisions are based on evidence, not marketing and promotion? w/ Sanket Dhruva @Yale_CRRIT https://t.co/nczw40JtuG
-
-
Mashup Score: 11Opinion | Is Industry Influence Driving LVAD Use by Cardiologists? - 11 month(s) ago
Clinical treatment decisions should be based on the best available evidence
Source: www.medpagetoday.comCategories: General Medicine News, PayerTweet-
Opinion | Industry influence seems to be driving LVAD use by cardiologists. How can we be sure clinical decisions are based on evidence, not marketing and promotion? w/ Sanket Dhruva @Yale_CRRIT https://t.co/nczw40JtuG
-
-
Mashup Score: 49Study: Many non-oncologic surrogate markers lack meta-analyses linking them to outcomes | RAPS - 11 month(s) ago
Over half of the non-oncologic surrogate markers listed in the US Food and Drug Administration@s (FDA) Adult Surrogate Endpoint Table do not have a meta-analysis of clinical trials evaluating the relationship between the treatment effect associated with the marker and a clinical outcome, according to a recent study published in JAMA.
Source: www.raps.orgCategories: General Medicine News, PayerTweet-
Study: Many surrogate markers used for pivotal trials of products to treat non-oncologic chronic diseases lack meta-analyses linking them to outcomes, raising uncertainty of their validity @JoshuaDWallach @Yale_CRRIT https://t.co/BmmP4LJj7A
-
-
Mashup Score: 49Study: Many non-oncologic surrogate markers lack meta-analyses linking them to outcomes | RAPS - 11 month(s) ago
Over half of the non-oncologic surrogate markers listed in the US Food and Drug Administration@s (FDA) Adult Surrogate Endpoint Table do not have a meta-analysis of clinical trials evaluating the relationship between the treatment effect associated with the marker and a clinical outcome, according to a recent study published in JAMA.
Source: www.raps.orgCategories: General Medicine News, PayerTweet-
Study: Many surrogate markers used for pivotal trials of products to treat non-oncologic chronic diseases lack meta-analyses linking them to outcomes, raising uncertainty of their validity @JoshuaDWallach @Yale_CRRIT https://t.co/BmmP4LJj7A
-
-
Mashup Score: 4David Egilman, Doctor Who Took On Drug Companies, Dies at 71 - 11 month(s) ago
His testimony as an expert witness in some 600 trials helped plaintiffs win billions of dollars in cases involving malfeasance by pharmaceutical makers.
Source: www.nytimes.comCategories: General Medicine News, PayerTweet-
RT @albertoruano8: Really sad to see that Dr Egilman passed away. https://t.co/TnzbQox7od He hosted @CristinaCandal at @BrownUniversity @Br…
-
-
Mashup Score: 30
The Philips CPAP nightmare exposes shortcomings in medical device regulation.
Source: www.statnews.comCategories: General Medicine News, PayerTweet-
In @statnews this morning, @ktkadakia, Vinay Rathi and I discuss the shortcomings in medical device regulation exposed by the Philips CPAP ongoing recall, and what a nightmare its been for patients https://t.co/1pcWMg5kDO
-
-
Mashup Score: 30
The Philips CPAP nightmare exposes shortcomings in medical device regulation.
Source: www.statnews.comCategories: General Medicine News, PayerTweet-
In @statnews this morning, @ktkadakia, Vinay Rathi and I discuss the shortcomings in medical device regulation exposed by the Philips CPAP ongoing recall, and what a nightmare its been for patients https://t.co/1pcWMg5kDO
-
RT @NCSP_Yale: 👏 Congrats to Yale NCSP alum, Nadir Ijaz, Md, MHS, on his publication in the Lancet Global Health! https://t.co/9QqNbxcMuZ h…